FDA to Address Data Integrity Concerns with China-Based Third-Party Testing Labs - In Compliance Magazine
Summary by In Compliance Magazine
1 Articles
1 Articles
All
Left
Center
Right
FDA to Address Data Integrity Concerns with China-Based Third-Party Testing Labs - In Compliance Magazine
The U.S. Food and Drug Administration (FDA) is raising concerns about the integrity of data submitted by two China-based testing laboratories in support of recent premarket medical device submissions. The post FDA to Address Data Integrity Concerns with China-Based Third-Party Testing Labs appeared first on In Compliance Magazine.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium